Right atrial catheter-related complications in pediatric oncology patients: The situation in a developing country

Pediatric Hematology and Oncology

Volumn 16, Issue 4, 1999, Pages 299-309

  Ertem, Mehmet ^a   Yavuz, Gülsan ^a   Aysev, Derya ^a   Ünal, Emel ^a   Gözdaşoǧlu, Sevgi ^a   Taçyildiz, Nurdan ^a   Cavdar, Ayhan ^a   Cin, Şükrü ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Central venous catheter; Children; Complication; Infection; Malignant disease

Indexed keywords

ARTICLE; BACTERIUM CULTURE; CANCER CHEMOTHERAPY; CANDIDA; CATHETER INFECTION; CHILD; CHILDHOOD CANCER; DEVELOPING COUNTRY; DRUG DELIVERY SYSTEM; FUNGUS CULTURE; HEART CATHETERIZATION; HEART RIGHT ATRIUM; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; SEPSIS; STAPHYLOCOCCUS; TURKEY (REPUBLIC); VASCULAR ACCESS;

ADOLESCENT; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; HUMANS; INFANT; INFECTION; NEOPLASMS;

EID: 0032986094     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800199277128     Document Type: Article

References (25)

1. Iannacci L, Piomelli S. Supportive care for children with cancer: Guidelines for the Children's Cancer Study Group. Use of venous access lines. Am J Pediatr Hematol Oncol. 1984;6:277-281.
2. van Hoff J, Berg AT, Seashore JH. The effect of right atrial catheters on infectious complications of chemotherapy in children. J Clin Oncol. 1990;8:1255-1262.
3. Shapiro ED, Wald ER, Nelson KA, et al. Broviac catheter-related bacteremia in oncology patients. Am J Dis Child. 1982;136:679-681.
4. King DR, Komer M, Hoffman J, et al. Broviac catheter sepsis: the natural history of an iatrogenic infection. J Pediatr Surg. 1985;6:728-733.
5. Viscoli C, Garaventa A, Boni L, et al. Role of Broviac catheters in infections in children with cancer. Pediatr Infect Dis J. 1988;7:556-560.
6. Dawson S, Pai MK, Smith S. et al. Right atrial catheters in children with cancer: a decade of experience in the use of tunnelled, exteriorized devices at a single institution. Am J Ped Hematol Oncol. 1991;13:126-129.
7. Mueller BU, Skelton J, Callender DP, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol. 1992;10:1943-1948.
8. Ingram J, Weitzman S, Greenberg ML, et al. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol. 1991;13:130-136.
9. Darbyshire PJ, Weightman NC, Speller DC. Problems associated with indwelling central venous catheters. Arch Dis Child. 1985;60:129-134.
10. Wurzel CL, Halom K, Feldman JG, et al. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child. 1988;142:536-540.
11. Cameron GS. Central venous catheters for children with malignant disease: surgical issues. J Pediatr Surg. 1987;22:702-704.
12. Hartman GE, Shochat SJ. Management of septic complications associated with Silastic catheters in childhood malignancy. Pediatr Infect Dis J. 1987;6:1042-1047.
13. Johnson PR, Decker MD, Edwards KM, et al. Frequency of Broviac catheter infections in pediatric oncology patients. J Infect Dis. 1986;154:570.
14. Wing EJ, Norden CW, Shadduck RK, et al. Use of quantitative bacteriologic techniques to diagnose catheter-related sepsis. Arch Intern Med. 1979;139:482-483.
15. Lowder JN, Lazarus HM, Herzig RH. Bacteremias and fungemias in oncologic patients with central venous catheters: changing spectrum of infection. Arch Intern Med. 1982;142:1456-1459.
16. Sanz MA, Such M, Rafecas FJ, et al. Staphylococcus epidermidis infections in acute myeloblastic leukemia patients fitted with Hickman catheters. Lancet. 1983;2:1191.
17. Wade JC, Schimpff SC, Newman KA, et al. Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med. 1982;97:503-508.
18. Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis. 1982;146:479-482.
19. Gray ED, Peters G, Verstegen M, et al. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet. 1984;1:365-367.
20. Decker MD, Edwards KM. Central venous catheter infections. Pediatr Clin North Am. 1988;35:579-612.
21. Wang EE, Prober CG, Ford-Jones L, et al. The management of central venous catheter infections. Pediatr Infect Dis. 1984;3:110.
22. Hockenberry MJ, Schultz WH, Bennett B, et al. Experience with minimal complications in implanted catheters in children. Am J Pediatr Hematol Oncol. 1989;11:295-299.
23. Greene FL, Moore W, Strickland G, et al. Comparison of a totally implantable access device for chemotherapy and long-term percutaneous catheterization (Broviac). South Med J. 1988;30:181-184.
24. Shulman RJ, Rahman S, Mahoney D, et al. A totally implanted venous access system used in pediatric patients with cancer. J Clin Oncol. 1987;5:137-140.
25. Mirro J, Rao BN, Stokes DC, et al. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol. 1989;7:214-222.